Diabetes type 2 risk gene Dusp8 is associated with altered sucrose reward behavior in mice and humans.


Journal

Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837

Informations de publication

Date de publication:
01 2021
Historique:
received: 27 08 2020
revised: 28 09 2020
accepted: 18 10 2020
pubmed: 2 11 2020
medline: 1 7 2021
entrez: 1 11 2020
Statut: ppublish

Résumé

Dusp8 is the first GWAS-identified gene that is predominantly expressed in the brain and has previously been linked with the development of diabetes type 2 in humans. In this study, we unravel how Dusp8 is involved in the regulation of sucrose reward behavior. Female, chow-fed global Dusp8 WT and KO mice were tested in an observer-independent IntelliCage setup for self-administrative sucrose consumption and preference followed by a progressive ratio task with restricted sucrose access to monitor seeking and motivation behavior. Sixty-three human carriers of the major C and minor T allele of DUSP8 SNP rs2334499 were tested for their perception of food cues by collecting a rating score for sweet versus savory high caloric food. Dusp8 KO mice showed a comparable preference for sucrose, but consumed more sucrose compared to WT mice. In a progressive ratio task, Dusp8 KO females switched to a "trial and error" strategy to find sucrose while control Dusp8 WT mice kept their previously established seeking pattern. Nonetheless, the overall motivation to consume sucrose, and the levels of dopaminergic neurons in the brain areas NAcc and VTA were comparable between genotypes. Diabetes-risk allele carriers of DUSP8 SNP rs2334499 preferred sweet high caloric food compared to the major allele carriers, rating scores for savory food remained comparable between groups. Our data suggest a novel role for Dusp8 in the perception of sweet high caloric food as well as in the control of sucrose consumption and foraging in mice and humans.

Sections du résumé

BACKGROUND
Dusp8 is the first GWAS-identified gene that is predominantly expressed in the brain and has previously been linked with the development of diabetes type 2 in humans. In this study, we unravel how Dusp8 is involved in the regulation of sucrose reward behavior.
METHODS
Female, chow-fed global Dusp8 WT and KO mice were tested in an observer-independent IntelliCage setup for self-administrative sucrose consumption and preference followed by a progressive ratio task with restricted sucrose access to monitor seeking and motivation behavior. Sixty-three human carriers of the major C and minor T allele of DUSP8 SNP rs2334499 were tested for their perception of food cues by collecting a rating score for sweet versus savory high caloric food.
RESULTS
Dusp8 KO mice showed a comparable preference for sucrose, but consumed more sucrose compared to WT mice. In a progressive ratio task, Dusp8 KO females switched to a "trial and error" strategy to find sucrose while control Dusp8 WT mice kept their previously established seeking pattern. Nonetheless, the overall motivation to consume sucrose, and the levels of dopaminergic neurons in the brain areas NAcc and VTA were comparable between genotypes. Diabetes-risk allele carriers of DUSP8 SNP rs2334499 preferred sweet high caloric food compared to the major allele carriers, rating scores for savory food remained comparable between groups.
CONCLUSION
Our data suggest a novel role for Dusp8 in the perception of sweet high caloric food as well as in the control of sucrose consumption and foraging in mice and humans.

Identifiants

pubmed: 33131190
doi: 10.1002/brb3.1928
pmc: PMC7821601
doi:

Substances chimiques

Sucrose 57-50-1
DUSP8 protein, mouse EC 3.1.3.16
DUSP8 protein, human EC 3.1.3.48
Dual-Specificity Phosphatases EC 3.1.3.48

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e01928

Informations de copyright

© 2020 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

Références

Pharmacol Rev. 2016 Apr;68(2):242-63
pubmed: 26772794
N Engl J Med. 2012 Oct 11;367(15):1387-96
pubmed: 22998338
Circ Res. 2016 Jul 8;119(2):249-60
pubmed: 27225478
Obes Rev. 2016 Feb;17(2):159-77
pubmed: 26644270
Neurosci Biobehav Rev. 2000 Mar;24(2):173-98
pubmed: 10714382
Nature. 2009 Dec 17;462(7275):868-74
pubmed: 20016592
J Neurosci. 2016 Nov 9;36(45):11469-11481
pubmed: 27911750
Psychopharmacology (Berl). 2007 Apr;191(3):391-431
pubmed: 17072591
Physiol Behav. 2014 Sep;136:22-30
pubmed: 24874776
Ciba Found Symp. 1984;107:3-29
pubmed: 6437774
J Neurochem. 1995 Oct;65(4):1823-33
pubmed: 7561881
Neurosci Biobehav Rev. 2015 Oct;57:350-64
pubmed: 26432503
Behav Brain Res. 2018 Jan 30;337:61-69
pubmed: 28964912
Trends Neurosci. 2011 Oct;34(10):548-59
pubmed: 21889806
Diabetes Care. 2015 Jun;38(6):1044-50
pubmed: 25795413
Nat Genet. 2012 Sep;44(9):981-90
pubmed: 22885922
J Biol Chem. 1996 Nov 1;271(44):27205-8
pubmed: 8910287
Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1266-77
pubmed: 21411768
Br J Sports Med. 2016 Apr;50(8):496-504
pubmed: 27044603
Cell Signal. 2004 Jul;16(7):769-79
pubmed: 15115656
J Neurosci. 2007 Oct 17;27(42):11242-53
pubmed: 17942718
Appetite. 2014 Sep;80:41-54
pubmed: 24816323
Hippocampus. 2000;10(4):411-9
pubmed: 10985280
Brain Res. 2010 Sep 2;1350:43-64
pubmed: 20388498
Am J Clin Nutr. 2013 Mar;97(3):517-23
pubmed: 23364017
Brain Behav. 2021 Jan;11(1):e01928
pubmed: 33131190
Sci Rep. 2019 Dec 20;9(1):19483
pubmed: 31862894
Behav Brain Res. 2001 Dec 14;127(1-2):13-23
pubmed: 11718882
Curr Obes Rep. 2017 Jun;6(2):217-228
pubmed: 28434108
J Clin Invest. 2020 Nov 2;130(11):6093-6108
pubmed: 32780722
Lancet Diabetes Endocrinol. 2020 Jun;8(6):524-534
pubmed: 32445739
J Clin Invest. 2019 Aug 5;129(10):4058-4071
pubmed: 31380808
Diabetologia. 2013 Jul;56(7):1520-30
pubmed: 23620057
Nat Commun. 2017 May 04;8:15259
pubmed: 28469281
Neurosci Biobehav Rev. 2013 May;37(4):681-96
pubmed: 23415703
Biol Psychiatry. 2017 May 1;81(9):748-756
pubmed: 26555354
Cell. 2015 Jan 29;160(3):528-41
pubmed: 25635460
Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
pubmed: 8401595
Nat Rev Endocrinol. 2020 Apr;16(4):202-212
pubmed: 32099086
Neuron. 2016 Jun 15;90(6):1286-1298
pubmed: 27238864

Auteurs

Peter Baumann (P)

Research Unit Neurobiology of Diabetes, Helmholtz Zentrum München, Neuherberg, Germany.
Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.
Neurobiology of Diabetes, TUM School of Medicine, Technical University of Munich, Munich, Germany.

Sonja C Schriever (SC)

Research Unit Neurobiology of Diabetes, Helmholtz Zentrum München, Neuherberg, Germany.
Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.

Stephanie Kullmann (S)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
Department of Internal Medicine IV, University Hospital of Tübingen, Tübingen, Germany.

Annemarie Zimprich (A)

German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Institute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Chair of Developmental Genetics, c/o Helmholtz Zentrum München, Technische Universität München-Weihenstephan, Neuherberg, Germany.

Andreas Peter (A)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital of Tübingen, Tübingen, Germany.

Valerie Gailus-Durner (V)

German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.

Helmut Fuchs (H)

German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.

Martin Hrabe de Angelis (M)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Chair of Experimental Genetics, School of Life Science Weihenstephan, Technische Universität München, Freising, Germany.

Wolfgang Wurst (W)

Institute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Chair of Developmental Genetics, c/o Helmholtz Zentrum München, Technische Universität München-Weihenstephan, Neuherberg, Germany.
German Center for Neurodegenerative Diseases (DZNE) Site Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität München, Munich, Germany.

Matthias H Tschöp (MH)

Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.
Division of Metabolic Diseases, Technische Universität München, Munich, Germany.

Martin Heni (M)

German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
Department of Internal Medicine IV, University Hospital of Tübingen, Tübingen, Germany.
Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital of Tübingen, Tübingen, Germany.

Sabine M Hölter (SM)

German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Institute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Chair of Developmental Genetics, c/o Helmholtz Zentrum München, Technische Universität München-Weihenstephan, Neuherberg, Germany.

Paul T Pfluger (PT)

Research Unit Neurobiology of Diabetes, Helmholtz Zentrum München, Neuherberg, Germany.
Institute for Diabetes and Obesity, Helmholtz Zentrum München, Neuherberg, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.
Neurobiology of Diabetes, TUM School of Medicine, Technical University of Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH